Related Experiment Videos
Adult onset reducing body myopathy
D Figarella-Branger1, G A Putzu, C Bouvier-Labit
1Laboratoire de Biopathologie Nerveuse et Musculaire, Faculté de Médecine, Marseille, France.
Neuromuscular Disorders : NMD
|January 5, 2000
Summary
This study details a rare case of late-onset scapuloperoneal syndrome in a young woman, revealing unique protein compositions within muscle-reducing bodies. The findings suggest reducing body myopathy can manifest later in life.
Area of Science:
- Neurology
- Muscle Biology
- Genetics
Background:
- Scapuloperoneal syndrome is a rare neuromuscular disorder characterized by progressive muscle weakness.
- Late-onset presentations of this syndrome are uncommon, making early diagnosis and understanding challenging.
Observation:
- A 28-year-old woman presented with slowly progressive scapuloperoneal syndrome starting at age 24, with diffuse weakness developing 4 years later.
- Muscle biopsy revealed type I fiber predominance, elevated creatine kinase, and mixed neurogenic/myogenic patterns on EMG.
- Unique 'reducing bodies' were identified within muscle fibers, showing specific protein immunoreactivity.
Findings:
- Reducing bodies demonstrated strong immunoreactivity for dystrophin, alpha-sarcoglycan, vimentin, and ubiquitin.
- Western blot analysis indicated increased expression of dystrophin, vimentin, and desmin.
- Ultrastructural examination revealed reducing bodies composed of tubulofilamentous material, with peripheral desmin-positive material.
Implications:
- This case highlights the diverse protein composition of reducing bodies in myopathies.
- The findings suggest that reducing body myopathy can present as a late-onset condition.
- Further research into the pathogenesis of reducing body myopathy is warranted.